In a breakthrough that could reshape how we approach cancer drug discovery, researchers have developed a powerful intracellular screening platform that identifies covalent peptide inhibitors capable of irreversibly shutting down oncogenic transcription factors. A New Way to Target the ‘Undruggables’ Transcription factors, the master regulators of gene expression, have long presented a major challenge in…